MUTATIONS IN THE NS5A REGION OF HEPATITIS C VIRUS GENOTYPE 2A AND CORRELATION WITH RESPONSE TO PEGYLATED-INTERFERON-ALPHA 2B AND RIBAVIRIN COMBINATION THERAPY

被引：0
|
作者：
Hayashi, Kazuhiko [1 ]
Katano, Yoshiaki [1 ]
Ishigami, Masatoshi [1 ]
Nakano, Isao [1 ]
Goto, Hidemi [1 ]
机构：
[1] Nagoya Univ, Nagoya, Aichi 4648601, Japan
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
796
引用
收藏
页码：677A / 677A
页数：1
相关论文
共 50 条
  • [41] Mutations in the E2-PePHD region of hepatitis C virus genotype-3a and correlation with response to interferon and ribavirin combination therapy in Pakistani patients
    Afzal, Samia
    Idrees, Muhammad
    Akram, Madiha
    Awan, Zunaira
    Khubaib, Bushra
    Aftab, Mahwish
    Fatima, Zareen
    Badar, Sadaf
    Hussain, Abrar
    VIROLOGY JOURNAL, 2010, 7
  • [42] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis C A Meta-Analysis
    Flori, Nicolas
    Funakoshi, Natalie
    Duny, Yohan
    Valats, Jean-Christophe
    Bismuth, Michael
    Christophorou, Dimitri
    Daures, Jean-Pierre
    Blanc, Pierre
    DRUGS, 2013, 73 (03) : 263 - 277
  • [43] Mutations in NS5A region and response to interferon in HCV genotype 2 infection.
    Murakami, T
    Enomoto, N
    Asahina, Y
    Izumi, N
    Marumo, F
    Sato, C
    HEPATOLOGY, 1996, 24 (04) : 127 - 127
  • [44] Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes
    Frangeul, L
    Cresta, P
    Perrin, M
    Lunel, F
    Opolon, P
    Agut, H
    Huraux, JM
    HEPATOLOGY, 1998, 28 (06) : 1674 - 1679
  • [45] Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy
    Hamano, K
    Sakamoto, N
    Enomoto, N
    Izumi, N
    Asahina, Y
    Kurosaki, M
    Ueda, E
    Tanabe, Y
    Maekawa, S
    Itakura, J
    Watanabe, H
    Kakinuma, S
    Watanabe, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (09) : 1401 - 1409
  • [46] Incidence of retinopathy in chronic Hepatitis C patients treated with pegylated interferon alpha 2a and ribavirin combination therapy
    Kashif, Muhammad
    Saleem, Muhammad Khurram
    Farooka, Imran Khan
    Husnain, Amino
    Siddiqui, Arif Mahmood
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2015, 31 (01) : 174 - 177
  • [47] Combination therapy with pegylated interferon-A 2b and ribavirin in naive patients with chronic hepatitis C virus inection.
    Kallinowski, B
    Engler, S
    Bauer, E
    Stremmel, W
    Rossol, S
    HEPATOLOGY, 2002, 36 (04) : 580A - 580A
  • [48] Triple combination of pegylated interferon alpha 2b, ribavirin and amantadine for treatment of chronic hepatitis
    Younossi, ZM
    McCullough, AJ
    Barnes, DS
    Post, A
    Ong, JP
    Mullen, KD
    Carey, WD
    O'Shea, R
    Levinthal, G
    Gramlich, T
    Martin, LM
    Bringman, D
    Tavill, A
    Ferguson, R
    GASTROENTEROLOGY, 2003, 124 (04) : A781 - A781
  • [49] Interferon Alpha 2b in Combination with Ribavirin as a Treatment for Chronic Hepatitis C
    Mandokhel, Sherbet Khan
    Aziz-U-Rehman
    Khan, Mohammad Saleem
    Azeemullah
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 168 - 171
  • [50] Mutations in the NS5A gene are associated with response to interferon plus ribavirin combination therapy in patients with chronic hepatitis C virus 3a infection
    Ullah, Sajjad
    Rehman, Habib U.
    Idrees, Muhammad
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (10) : 1146 - 1151
12345